Services

We can perform proof of concept / mechanism of action assays, assay development and primary or secondary screenings for YOU.

For primary screening, we have different libraries (Prestwick, Enzo, …) available. Contact us for more information!

Choose below your preferred domain.

Look at our scientific posters

• 
  Poster: High Content Screening in 3D models including the tumor Extracellular MatrixOctober 18, 2023
• 
  Poster: Bridging the gap between in vitro & in vivo: 3D cell culture considering the extracellular matrix (ECM) – A focus on cancer modelsJune 14, 2023
• 
  Poster: 3D cell culture taking into account the extracellular matrix for phenotypic screening in the frame of Parkinson’s disease (SLAS Building Biology in 3D symposium)April 21, 2023
• 
  Poster: An Extracellular Matrix-like hydroscaffold for 3D cell culture to bring the gap between in vitro & in vivo: focus on cancer models (SLAS Building Biology in 3D symposium)April 21, 2023
• 
  Poster: An Extracellular Matrix-like hydroscaffold for 3D cell culture to bring the gap between in vitro & in vivo: focus on cancer modelsMarch 29, 2023
• 
  Poster : BIOMIMESYS®, a ready-to-use ECM for Relevant Phenotypic ScreeningMarch 13, 2023
• 
  Poster (OncoLilleDays2022) – Mechanobiological characterization of a 3D in vitro pancreatic ductal adenocarcinoma model and the study of tumor-stroma interactionNovember 25, 2022
• 
  Poster : Development of personalized therapeutic targeting in lung cancer with METex14 mutationNovember 21, 2022
• 
  Poster – Including the matricial tumoral microenvironment in 3D in vitro models by using a Hyaluronic-Acid-based hydroscaffold™November 2, 2022
• 
  Poster – (ECM 2022) Development of innovative hiPSC-based model including an innovative 3D modified hyaluronic acid hydroscaffold for phenotypic screeningJuly 18, 2022
• 
  Poster – Importance of microenvironment in cerebral in vitro models for phenotypic screeningJuly 12, 2022
• 
  Poster – A single procedure to generate functional hiPSCs-derived liver organoids -Towards an innovative tool suitable for drug screeningMarch 15, 2022
• 
  Poster – BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physiological organs-on-chip (OoC)February 23, 2022
• 
  Poster – Importance of matricial and cellular microenvironments in in vitro models for drug discovery in Parkinson’s diseaseMay 19, 2021
• 
  Poster – Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotypic screening – Application on metabolic diseases – version DHU2020December 19, 2019
• 
  Poster – Development and automation of 3D innovative hiPSC-based liver organoids including the microenvironment for phenotypic screening – Application on metabolic diseasesSeptember 16, 2019
• 
  Poster – Development of a new liver-on-chip including BIOMIMESYS® technology for mimicking the liver extracellular matrix: first results and perspectivesAugust 26, 2019
• 
  Poster – Impact of the composition and stiffness of a 3D hyaluronic acid-based hydroscaffold on breast cancer cell growth and CD44 expressionMay 14, 2019
• 
  Poster – A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldFebruary 6, 2019
• 
  Poster – Characterisation of 3D cultured primary human hepatocytes and HepaRG for DMSO-free preclinical toxicity testingNovember 15, 2018